T2 Biosystems
LEXINGTON, Mass.--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced...
FierceMedicalDevices
/
October 2, 2012
T2 Biosystems
Molecular diagnostics firm T2 Biosystems is set to begin a clinical trial for its first assay targeting Candida fungal infections...
GenomeWeb
/
January 20, 2012
T2 Biosystems
When a patient is ill with an unknown infection, time is of the essence. But detecting the root cause and determining the best...
Boston.com
/
January 2, 2012
T2 Biosystems
LEXINGTON, MA – T2 Biosystems® announced today that it has closed a $23 million series D financing. The round was led by new...
Release
/
August 10, 2011
T2 Biosystems
By Katherine Bourzac A startup called T2 Biosystems is developing a test that uses magnetic nanoparticles to detect...
MIT Technology Review
/
April 15, 2011
T2 Biosystems
Data Presented at Annual Meeting of Mycoses Study Group Demonstrates Rapid Identification of the Most Deadly Form of Common...
Release
/
April 7, 2011
T2 Biosystems
Having just sold Cytyc Development Corp. to Hologic in 2007 for $6.2 billion, John McDonough says he fully intended to stay in an...
Medical Device & Diagnostic Industry (MDDI) Magazine
/
December 15, 2010
T2 Biosystems
Cambridge, MA - T2 Biosystems, Inc., a company developing the first point-of-care medical diagnostic products that enable rapid...
Release
/
October 8, 2010
T2 Biosystems
Patients with weakened immune systems must be monitored closely to check for infections or other dangerous events. T2 Biosystems...
VentureWire
/
May 25, 2010
T2 Biosystems
Cambridge, MA -- T2 Biosystems, Inc., a company developing the first decentralized clinical diagnostic solution that eliminates...
Release
/
May 25, 2010
